{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/23/3315699/0/fr/Communiqu%C3%A9-de-presse-Cenrifki-tolebrutinib-de-Sanofi-approuv%C3%A9-dans-l-UE-comme-premier-m%C3%A9dicament-ciblant-la-progression-du-handicap-dans-la-scl%C3%A9rose-en-plaques-secondairement-progr.html", "message": "News view counter 811103 successfully enlarged"}